Literature DB >> 25155483

CD38 expression in early B-cell precursors contributes to extracellular signal-regulated kinase-mediated apoptosis.

Héctor Romero-Ramírez1, Monserrat Teresa Morales-Guadarrama, Rosana Pelayo, Rubén López-Santiago, Leopoldo Santos-Argumedo.   

Abstract

CD38 is a 45,000 molecular weight transmembrane protein that is expressed in immature and mature lymphocytes. However, the expression and function of CD38 during B-cell differentiation in mice is poorly understood. Here, we report that CD38 is expressed from the earliest stages of B-cell development. Pre-pro-B, pro-B, pre-B and immature B cells from murine bone marrow all stained positive for CD38. Interestingly, CD38 expression increases with B-cell maturation. To assess the role of CD38 during B-cell maturation, CD38-deficient mice were analysed. CD38(-/-) mice showed a significant increase in both the frequency of B-lineage cells and the absolute numbers of pre-pro-B cells in bone marrow; however, no other differences were observed at later stages. CD38 cross-linking in Ba/F3 cells promoted apoptosis and marked extracellular signal-regulated kinase (ERK) phosphorylation, and these effects were reduced by treatment with the mitogen-activated protein kinase/ERK kinase inhibitor PD98059, and similar effects were observed in B-cell precursors from bone marrow. These data demonstrate that B-cell precursors in mouse bone marrow express functional CD38 and implicate the early ligation of CD38 in the ERK-associated regulation of the B-lineage differentiation pathway.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  CD38; bone marrow; extracellular signal-regulated kinase; mouse B-cell development

Mesh:

Substances:

Year:  2015        PMID: 25155483      PMCID: PMC4298421          DOI: 10.1111/imm.12370

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  52 in total

Review 1.  The MEK/ERK cascade: from signaling specificity to diverse functions.

Authors:  Yoav D Shaul; Rony Seger
Journal:  Biochim Biophys Acta       Date:  2006-10-19

2.  CD38 cross-linking enhances TLR-induced B cell proliferation but decreases IgM plasma cell differentiation.

Authors:  Nataly Manjarrez-Orduño; Miguel E Moreno-García; Katja Fink; Leopoldo Santos-Argumedo
Journal:  Eur J Immunol       Date:  2007-02       Impact factor: 5.532

Review 3.  Signaling properties of CD38 in the mouse immune system: enzyme-dependent and -independent roles in immunity.

Authors:  Frances E Lund
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

4.  Structure and enzymatic functions of human CD38.

Authors:  Hon Cheung Lee
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

5.  CD38 and CD157: biological observations to clinical therapeutic targets.

Authors:  Amy Warenda Czura; Christopher J Czura
Journal:  Mol Med       Date:  2006 Nov-Dec       Impact factor: 6.354

6.  CD38 ligation inhibits normal and leukemic myelopoiesis.

Authors:  E Todisco; T Suzuki; K Srivannaboon; E Coustan-Smith; S C Raimondi; F G Behm; A Kitanaka; D Campana
Journal:  Blood       Date:  2000-01-15       Impact factor: 22.113

7.  CD38 signal transduction in human B cell precursors. Rapid induction of tyrosine phosphorylation, activation of syk tyrosine kinase, and phosphorylation of phospholipase C-gamma and phosphatidylinositol 3-kinase.

Authors:  O Silvennoinen; H Nishigaki; A Kitanaka; M Kumagai; C Ito; F Malavasi; Q Lin; M E Conley; D Campana
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

8.  Chemotaxis of mouse bone marrow neutrophils and dendritic cells is controlled by adp-ribose, the major product generated by the CD38 enzyme reaction.

Authors:  Santiago Partida-Sanchez; Andreas Gasser; Ralf Fliegert; Cornelia C Siebrands; Werner Dammermann; Guixiu Shi; Betty J Mousseau; Adriana Sumoza-Toledo; Harivadan Bhagat; Timothy F Walseth; Andreas H Guse; Frances E Lund
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

9.  CD38 induces differentiation of immature transitional 2 B lymphocytes in the spleen.

Authors:  Juan C Rodríguez-Alba; Miguel E Moreno-García; Claudia Sandoval-Montes; Víctor H Rosales-Garcia; Leopoldo Santos-Argumedo
Journal:  Blood       Date:  2008-01-25       Impact factor: 22.113

10.  Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.

Authors:  T Lamkin; J Brooks; G Annett; W Roberts; K Weinberg
Journal:  Leukemia       Date:  1994-11       Impact factor: 11.528

View more
  3 in total

1.  Chemical modulation of apoptosis in molluscan cell cultures.

Authors:  Andrey Victorovich Boroda; Yulia Olegovna Kipryushina; Nelly Adolphovna Odintsova
Journal:  Cell Stress Chaperones       Date:  2019-06-22       Impact factor: 3.667

Review 2.  Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.

Authors:  Tiziana Vaisitti; Francesca Arruga; Giulia Guerra; Silvia Deaglio
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

3.  Detection of Human CD38 Using Variable Lymphocyte Receptor (VLR) Tetramers.

Authors:  Srijit Khan; Yanling Liu; Laura M Ernst; Leslie Y T Leung; Patrick Budylowski; Shilan Dong; Paolo Campisi; Evan J Propst; Nikolaus E Wolter; Eyal Grunebaum; Mario Ostrowski; Götz R A Ehrhardt
Journal:  Cells       Date:  2020-04-12       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.